Effect of timing, dose and interstitial versus nanoparticle delivery of tumor necrosis factor alpha in combinatorial adjuvant cryosurgery treatment of ELT-3 uterine fibroid tumor

Cryo-Letters

Volumn 31, Issue 1, 2010, Pages 50-62

  Jiang, Jing ^a   Bischof, John ^a,b  

^a University of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cryosurgery; CYT 6091; Drug delivery; Leiomyoma; TNF

Indexed keywords

NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CRYOSURGERY; DISEASE MODEL; DOSE RESPONSE; DRUG DELIVERY SYSTEM; FEMALE; LEIOMYOMA; MALE; METHODOLOGY; MOUSE; MULTIMODALITY CANCER THERAPY; NUDE MOUSE; REMISSION; TUMOR CELL CULTURE; UTERUS CANCER;

ANIMALS; COMBINED MODALITY THERAPY; CRYOSURGERY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; FEMALE; LEIOMYOMA; MALE; MICE; MICE, NUDE; NANOPARTICLES; REMISSION INDUCTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UTERINE NEOPLASMS;

ANIMALIA; MUS MUSCULUS;

EID: 77950360687     PISSN: 01432044     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ablin RJ, Gonder MJ, Soanes WA. Elution of cell-bound anti-prostatic epithelial antibodies after multiple cryotherapy of carcinoma of the prostate. Cryobiology 1974; 11:218-221
2. Al-Hendy A, Salama S. Gene therapy and uterine leiomyoma: a review. Hum Reprod Update 2006; 12: 385-400.
3. Beutler B, Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Annu Rev Immunol 1989; 7: 625-655
4. Bischof J, Fahssi W, Smith D, Nagel T, Swanlund D. A parametric study of freezing injury in ELT-3 uterine leiomyoma tumour cells. Hum Reprod 2001; 16: 340-348
5. Bradley EA, Reidy JF, Forman RG, Jarosz J, Braude PR. Transcatheter uterine artery embolisation to treat large uterine fibroids. Br J Obstet Gynaecol 1998; 105: 235-240
6. Chao BH, He X, Bischof JC. Pre-treatment inflammation induced by TNF-alpha augments cryosurgical injury on human prostate cancer. Cryobiology 2004; 49: 10-27.
7. Cooper IS. Cryogenic surgery: a new method of destruction or extirpation of benign or malignant tissues. N Engl J Med 1963; 268: 743-749
8. Cowan BD, Sewell PE, Howard JC, Arriola RM, Robinette LG. Interventional magnetic resonance imaging cryotherapy of uterine fibroid tumors: preliminary observation. Am J Obstet Gynecol 2002; 186: 1183-1187
9. Exacoustos C, Zupi E, Marconi D, et al. Ultrasound-assisted laparoscopic cryomyolysis: two- and three-dimensional findings before, during and after treatment. Ultrasound Obstet Gynecol 2005; 25: 393-400.
10. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998; 37: 171-186
11. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 1985; 82: 8667-8671
12. Gazzaniga S, Bravo A, Goldszmid SR, et al. Inflammatory changes after cryosurgeryinduced necrosis in human melanoma xenografted in nude mice. J Invest Dermatol 2001; 116: 664-671
13. Goel R, Shah N, Visaria R, Paciotti GF, Bischof JC. Biodistribution of TNF-alphacoated gold nanoparticles in an in vivo model system. Nanomed 2009; 4: 401-410
14. Goel R, Swanlund D, Coad J, Paciotti GF, Bischof JC. TNF-alpha-based accentuation in cryoinjury-dose, delivery, and response. Mol Cancer Ther 2007; 6: 2039-2047
15. Goodwin SC, Walker WJ. Uterine artery embolization for the treatment of uterine fibroids. Curr Opin Obstet Gynecol 1998; 10: 315-320
16. Han B, Iftekhar A, Bischof JC. Improved cryosurgery by use of thermophysical and inflammatory adjuvants. Technol Cancer Res Treat 2004; 3: 103-111
17. Hieber U, Heim ME. Tumor necrosis factor for the treatment of malignancies. Oncology 1994; 51: 142-153
18. Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002; 60: 40-49
19. Howe SR, Gottardis MM, Everitt JI, Goldsworthy TL, Wolf DC, Walker C. Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. Am J Pathol 1995; 146: 1568-1579
20. Hutchins FL, Jr., Worthington-Kirsch R, Berkowitz RP. Selective uterine artery embolization as primary treatment for symptomatic leiomyomata uteri. J Am Assoc Gynecol Laparosc 1999; 6: 279-284
21. Jiang J, Goel R, Iftekhar MA, et al. Tumor necrosis factor-alpha-induced accentuation in cryoinjury: mechanisms in vitro and in vivo. Mol Cancer Ther 2008; 7: 2547-2555
22. Kircheis R, Ostermann E, Wolschek MF, et al. Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity. Cancer Gene Ther 2002; 9: 673-680
23. Kono H, Wheeler MD, Rusyn I, et al. Gender differences in early alcohol-induced liver injury: role of CD 14, NF-kappaB, and TNF-alpha. Am J Physiol Gastrointest Liver Physiol 2000; 278: G652-61.
24. Kramer G, Steiner GE, Sokol P, et al. Local intratumoral tumor necrosis factor-alpha and systemic IFN-alpha 2b in patients with locally advanced prostate cancer. J Interferon Cytokine Res 2001; 21: 475-484
25. Libutti SK, Paciotti GF, Myer R, et al. Results of a completed phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine. Journal of Clinical Oncology 2009; 27: 3586.
26. Mauceri HJ, Hanna NN, Wayne JD, Hallahan DE, Hellman S, Weichselbaum RR. Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature. Cancer Res 1996; 56: 4311-4314
27. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163: 740-745
28. Paciotti GF, Myer L, Weinreich D, et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 2004; 11: 169-183
29. Partheniou F, Kelsey SM, Srinivasula SM, Newland AC, Alnemri ES, Jia L. c-IAP1 blocks TNFalpha-mediated cytotoxicity upstream of caspase-dependent and independent mitochondrial events in human leukemic cells. Biochem Biophys Res Commun 2001; 287: 181-189
30. Ravina JH, Bouret JM, Fried D, et al. [Value of preoperative embolization of uterine fibroma: report of a multicenter series of 31 cases]. Contrcept Fertil Sex 1995; 23: 45-49
31. Schacht V, Becker K, Szeimies RM, Abels C. Apoptosis and leucocyte-endothelium interactions contribute to the delayed effects of cryotherapy on tumours in vivo. Arch Dermatol Res 2002; 294: 341-348
32. Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999; 23: 109-13; discussion 13-14
33. Soanes WA, Ablin RJ, Gonder MJ. Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J Urol 1970; 104: 154-159
34. Srinivasan JM, Fajardo LF, Hahn GM. Mechanism of antitumor activity of tumor necrosis factor alpha with hyperthermia in a tumor necrosis factor alpha-resistant tumor. J Natl Cancer Inst 1990; 82: 1904-1910
35. Trevejo JM, Marino MW, Philpott N, et al. TNF-alpha -dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc Natl Acad Sci USA 2001; 98: 12162-12167
36. Turk TM, Rees MA, Pietrow P, Myers CE, Mills SE, Gillenwater JY. Determination of optimal freezing parameters of human prostate cancer in a nude mouse model. Prostate 1999; 38: 137-143
37. van der Veen AH, Eggermont AM, Seynhaeve AL, van T, ten Hagen TL. Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-alpha in soft tissue sarcoma bearing rats. Int J Cancer 1998; 77: 901-906
38. van Horssen R, Ten Hagen TL, Eggermont AM. TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 2006; 11: 397-408.
39. Van Zee KJ, Stackpole SA, Montegut WJ, et al. A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon. J Exp Med 1994; 179: 1185-1191
40. Visaria RK, Griffin RJ, Williams BW, et al. Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery. Mol. Cancer Ther 2006; 5: 1014-1020
41. Walker CL, Hunter D, Everitt JI. Uterine leiomyoma in the Eker rat: a unique model for important diseases of women. Genes Chromosomes Cancer 2003; 38: 349-356
42. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 1997; 94: 2557-2562
43. Zreik TG, Rutherford TJ, Palter SF, et al. Cryomyolysis, a new procedure for the conservative treatment of uterine fibroids. J Am Assoc Gynecol Laparosc 1998; 5: 33-38
44. Zupi E, Sbracia M, Marconi D, Munro MG. Myolysis of uterine fibroids: is there a role? Clin Obstet Gynecol 2006; 49: 821-833